COVID-19、流感与脓毒症住院后医学与精神健康后遗症的比较
这项基于加拿大安大略省的人群队列研究纳入379366例成人(中位年龄75岁,54%女性),比较COVID-19住院幸存者(26499例)与历史对照(流感17516例、脓毒症282473例)及同期脓毒症对照(52878例)在出院后1年内13种预设新发疾病的风险。COVID-19住院者1年静脉血栓栓塞风险较流感住院者升高(校正HR 1.77,95%CI 1.36-2.31),但所选缺血性和非缺血性脑血管及心血管疾病、神经系统疾病、类风湿关节炎及精神健康疾病风险较流感或脓毒症队列均无升高。作者认为,除静脉血栓栓塞风险升高外,COVID-19住院幸存者的急性期后医学与精神健康负担与其他急性感染性疾病相当,提示许多COVID-19急性期后后果可能与需要住院的感染严重程度相关,而非SARS-CoV-2感染的直接后果。
要点
- COVID-19住院幸存者1年静脉血栓栓塞风险较流感住院者升高:校正HR 1.77(95%CI 1.36-2.31)。
- COVID-19住院者所选缺血性和非缺血性脑血管及心血管疾病风险较流感或脓毒症队列无升高。
- COVID-19住院者神经系统疾病、类风湿关节炎及精神健康疾病风险较流感或脓毒症队列无升高。
- 作者认为,许多COVID-19急性期后后果可能与需住院的感染严重程度相关,而非SARS-CoV-2感染的直接后果。
适用人群与场景
- 研究纳入加拿大安大略省所有在2020年4月1日至2021年10月31日期间因COVID-19住院的成人,以及因流感或脓毒症住院的历史对照和因脓毒症住院的同期对照。
- 共纳入379366例成人,中位年龄75岁(IQR 63-85),54%为女性;其中COVID-19住院幸存者26499例,历史对照299989例(流感17516例、脓毒症282473例),同期脓毒症对照52878例。
研究设计与关键结果
- 研究类型为基于人群的队列研究,纳入379366例成人,比较COVID-19住院幸存者与流感、脓毒症住院对照在1年内13种预设新发疾病的风险。
- COVID-19住院者1年静脉血栓栓塞风险较流感住院者升高:校正HR 1.77(95%CI 1.36-2.31)。
- COVID-19住院者所选缺血性和非缺血性脑血管及心血管疾病、神经系统疾病、类风湿关节炎及精神健康疾病风险较流感或脓毒症队列均无升高。
证据类型、等级与局限
- 证据类型:基于人群的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,除静脉血栓栓塞风险升高外,COVID-19住院幸存者的急性期后医学与精神健康负担与其他急性感染性疾病相当,许多急性期后后果可能与需住院的感染严重程度相关,而非SARS-CoV-2感染的直接后果。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: People who survive hospitalization for COVID-19 are at risk for developing new cardiovascular, neurological, mental health, and inflammatory autoimmune conditions. It is unclear how posthospitalization risks for COVID-19 compare with those for other serious infectious illnesses.
OBJECTIVE: To compare risks of incident cardiovascular, neurological, and mental health conditions and rheumatoid arthritis in 1 year following COVID-19 hospitalization against 3 comparator groups: prepandemic hospitalization for influenza and hospitalization for sepsis before and during the COVID-19 pandemic.
DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study included all adults hospitalized for COVID-19 between April 1, 2020, and October 31, 2021, historical comparator groups of people hospitalized for influenza or sepsis, and a contemporary comparator group of people hospitalized for sepsis in Ontario, Canada.
EXPOSURE: Hospitalization for COVID-19, influenza, or sepsis.
MAIN OUTCOME AND MEASURES: New occurrence of 13 prespecified conditions, including cardiovascular, neurological, and mental health conditions and rheumatoid arthritis, within 1 year of hospitalization.
RESULTS: Of 379 366 included adults (median [IQR] age, 75 [63-85] years; 54% female), there were 26 499 people who survived hospitalization for COVID-19, 299 989 historical controls (17 516 for influenza and 282 473 for sepsis), and 52 878 contemporary controls hospitalized for sepsis. Hospitalization for COVID-19 was associated with an increased 1-year risk of venous thromboembolic disease compared with influenza (adjusted hazard ratio, 1.77; 95% CI, 1.36-2.31) but with no increased risks of developing selected ischemic and nonischemic cerebrovascular and cardiovascular disorders, neurological disorders, rheumatoid arthritis, or mental health conditions compared with influenza or sepsis cohorts.
CONCLUSIONS AND RELEVANCE: In this cohort study, apart from an elevated risk of venous thromboembolism within 1 year, the burden of postacute medical and mental health conditions among those who survived hospitalization for COVID-19 was comparable with other acute infectious illnesses. This suggests that many of the postacute consequences of COVID-19 may be related to the severity of infectious illness necessitating hospitalization rather than being direct consequences of infection with SARS-CoV-2.
参考来源
- Quinn KL, Stukel TA, Huang A, et al. Comparison of Medical and Mental Health Sequelae Following Hospitalization for COVID-19, Influenza, and Sepsis. JAMA Intern Med. 2023. PMID: 37338892. doi:10.1001/jamainternmed.2023.2228
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。